Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia R Ball

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Cell Reports|June 14, 2018
Cell-of-Origin DNA Methylation Signatures Are Maintained during Colorectal CarcinogenesisFelix Bormann, Manuel Rodríguez-Paredes, Felix Lasitschka, et al.
Biomolecules|May 28, 2025
Celebrating Ulrik Ringborg: Multi-Omics-Based Patient Stratification for Precision Cancer TreatmentMaria-Veronica Teleanu, Annika Schneider, Claudia R Ball, et al.
Frontiers in Immunology|February 2, 2023
Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC modelRūta Veinalde, Gemma Pidelaserra-Martí, Coline Moulin, et al.
International Journal of Cancer|February 21, 2020
A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cellsLino Möhrmann, Martina K Zowada, Hendrik Strakerjahn, et al.
Cell Death and Differentiation|March 27, 2025
The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancersVida Kufrin, Annika Seiler, Silke Brilloff, et al.
Cancer Research|January 8, 2013
Specific elimination of CD133+ tumor cells with targeted oncolytic measles virusPatricia Bach, Tobias Abel, Christopher Hoffmann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivoFriederike Herbst, Claudia R Ball, Francesca Tuorto, et al.
Cell Stem Cell|October 11, 2011
Distinct types of tumor-initiating cells form human colon cancer tumors and metastasesSebastian M Dieter, Claudia R Ball, Christopher M Hoffmann, et al.
Cell Death Discovery|October 20, 2025
Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemiaSandra Küchler, Silke Brilloff, Silvia Schäfer, et al.
NPJ Precision Oncology|February 9, 2025
RevCAR-mediated T-cell response against PD-L1-expressing cells turns suppression into activationEugenia Crespo, Liliana R Loureiro, Antonia Stammberger, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Cell Reports|June 14, 2018
Cell-of-Origin DNA Methylation Signatures Are Maintained during Colorectal CarcinogenesisFelix Bormann, Manuel Rodríguez-Paredes, Felix Lasitschka, et al.
Biomolecules|May 28, 2025
Celebrating Ulrik Ringborg: Multi-Omics-Based Patient Stratification for Precision Cancer TreatmentMaria-Veronica Teleanu, Annika Schneider, Claudia R Ball, et al.
Frontiers in Immunology|February 2, 2023
Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC modelRūta Veinalde, Gemma Pidelaserra-Martí, Coline Moulin, et al.
International Journal of Cancer|February 21, 2020
A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cellsLino Möhrmann, Martina K Zowada, Hendrik Strakerjahn, et al.
Cell Death and Differentiation|March 27, 2025
The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancersVida Kufrin, Annika Seiler, Silke Brilloff, et al.
Cancer Research|January 8, 2013
Specific elimination of CD133+ tumor cells with targeted oncolytic measles virusPatricia Bach, Tobias Abel, Christopher Hoffmann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivoFriederike Herbst, Claudia R Ball, Francesca Tuorto, et al.
Cell Stem Cell|October 11, 2011
Distinct types of tumor-initiating cells form human colon cancer tumors and metastasesSebastian M Dieter, Claudia R Ball, Christopher M Hoffmann, et al.
Cell Death Discovery|October 20, 2025
Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemiaSandra Küchler, Silke Brilloff, Silvia Schäfer, et al.
NPJ Precision Oncology|February 9, 2025
RevCAR-mediated T-cell response against PD-L1-expressing cells turns suppression into activationEugenia Crespo, Liliana R Loureiro, Antonia Stammberger, et al.
Pageof 5